Clinical Trial: Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).

U.S., Oct. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07871669) titled 'Efficacy and Safety of TRA16 Administered Orally in Patients With Enteric Hyperoxaluria (EH).' on Oct. 07.

Brief Summary: A Phase II, Multi-center, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of TRA16 Administered Orally in Patients with Enteric Hyperoxaluria (EH).

Study Start Date: March 01, 2027

Study Type: INTERVENTIONAL

Condition: Enteric Hyperoxaluria

Intervention: DRUG: TRA16

TRA16 powder

DRUG: Placebo

Matching placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Wuhan Kangfude Urolithiasis Research Institute Co., Ltd.

Disclaimer: Curated by HT Syndication....